{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:16:12Z","timestamp":1786979772592,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,10,22]],"date-time":"2011-10-22T00:00:00Z","timestamp":1319241600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00213-011-2532-9","type":"journal-article","created":{"date-parts":[[2011,10,20]],"date-time":"2011-10-20T22:32:40Z","timestamp":1319149960000},"page":"799-807","source":"Crossref","is-referenced-by-count":23,"title":["The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning"],"prefix":"10.1007","volume":"220","author":[{"given":"Con","family":"Stough","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Papafotiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Swann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Ogden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Wesnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,22]]},"reference":[{"key":"2532_CR1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1076\/clin.17.4.446.27939","volume":"17","author":"C Back-Madruga","year":"2003","unstructured":"Back-Madruga C, Boone KB, Chang L, Grob CS, Lee A, Nations H, Poland RE (2003) Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users. Clin Neuropsychol 17:446\u2013459","journal-title":"Clin Neuropsychol"},{"key":"2532_CR2","doi-asserted-by":"crossref","unstructured":"Bosker WM, Kuypers KPC, Conen S, Ramaekers JG (2010) Dose-related effects of MDMA on psychomotor function and mood before, during, and after a night of sleep loss. Psychopharmacology: 1\u20138","DOI":"10.1007\/s00213-009-1767-1"},{"key":"2532_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-198916010-00001","volume":"16","author":"U Busto","year":"1989","unstructured":"Busto U, Bendayan R, Sellers EM (1989) Clinical pharmacokinetics of non-opiate abused drugs. Clin Pharmacokin 16:1\u201326","journal-title":"Clin Pharmacokin"},{"key":"2532_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/09595230601036945","volume":"26","author":"KJ Clemens","year":"2007","unstructured":"Clemens KJ, McGregor IS, Hunt GE, Cornish JL (2007) MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Drug Alcohol Rev 26:9\u201315","journal-title":"Drug Alcohol Rev"},{"key":"2532_CR5","first-page":"464","volume":"15","author":"J Cole","year":"2002","unstructured":"Cole J, Sumnall H, Grob C (2002) Sorted: ecstasy facts and fiction. Psychologist 15:464\u2013467","journal-title":"Psychologist"},{"key":"2532_CR6","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","volume":"104","author":"CC Cruickshank","year":"2009","unstructured":"Cruickshank CC, Dyer KR (2009) A review of the clinical pharmacology of methamphetamine. Addiction 104:1085\u20131099","journal-title":"Addiction"},{"key":"2532_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1360-0443.2003.00622.x","volume":"99","author":"L Degenhardt","year":"2004","unstructured":"Degenhardt L, Barker B, Topp L (2004) Patterns of ecstasy use in Australia: findings from a national household survey. Addiction 99:187\u2013195","journal-title":"Addiction"},{"key":"2532_CR8","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1360-0443.2007.01906.x","volume":"102","author":"L Degenhardt","year":"2007","unstructured":"Degenhardt L, Coffey C, Carlin JB, Moran P, Patton GC (2007) Who are the new amphetamine users? A 10-year prospective study of young Australians. Addiction 102:1269\u20131279","journal-title":"Addiction"},{"key":"2532_CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0269881108099214","volume":"24","author":"GJH Dumont","year":"2010","unstructured":"Dumont GJH, Schoemaker RC, Touw DJ, Sweep FCGJ, Buitelaar JK, Van Gerven JMA, Verkes RJ (2010) Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers. J Psychopharmacol 24:155\u2013164","journal-title":"J Psychopharmacol"},{"key":"2532_CR10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neubiorev.2010.04.008","volume":"35","author":"MJ Fern\u00e1ndez-Serrano","year":"2011","unstructured":"Fern\u00e1ndez-Serrano MJ, P\u00e9rez-Garc\u00eda M, Verdejo-Garc\u00eda A (2011) What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neurosci Biobehav R 35:377\u2013406","journal-title":"Neurosci Biobehav R"},{"key":"2532_CR11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF01997792","volume":"17","author":"AR Giovagnoli","year":"1996","unstructured":"Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E (1996) Trail making test: normative values from287 normal adult controls. Ital J Neurol Sci 17:305\u2013309","journal-title":"Ital J Neurol Sci"},{"key":"2532_CR12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","volume":"55","author":"AR Green","year":"2003","unstructured":"Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \"ecstasy\"). Pharmacol Rev 55:463\u2013508","journal-title":"Pharmacol Rev"},{"key":"2532_CR13","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/sj.npp.1301578","volume":"33","author":"CL Hart","year":"2008","unstructured":"Hart CL, Gunderson EW, Perez A, Kirkpatrick MG, Thurmond A, Comer SD, Foltin RW (2008) Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacol 33:1847\u20131855","journal-title":"Neuropsychopharmacol"},{"key":"2532_CR14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0893-133X(99)00116-5","volume":"22","author":"BA Johnson","year":"2000","unstructured":"Johnson BA, Ait-Daoud N, Wells LT (2000) Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on d-methamphetamine-induced cognitive and physiological changes in humans. Neuropsychopharmacol 22:504\u2013512","journal-title":"Neuropsychopharmacol"},{"key":"2532_CR15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1176\/appi.neuropsych.15.2.215","volume":"15","author":"AD Kalechstein","year":"2003","unstructured":"Kalechstein AD, Newton TF, Green M (2003) Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychi Clin N 15:215\u2013220","journal-title":"J Neuropsychi Clin N"},{"key":"2532_CR16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00213-006-0601-2","volume":"189","author":"AD Kalechstein","year":"2007","unstructured":"Kalechstein AD, De La Garza Ii R, Mahoney Iii JJ, Fantegrossi WE, Newton TF (2007) MDMA use and neurocognition: a meta-analytic review. Psychopharmacology 189:531\u2013537","journal-title":"Psychopharmacology"},{"key":"2532_CR17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/0269881105056670","volume":"19","author":"KPC Kuypers","year":"2005","unstructured":"Kuypers KPC, Ramaekers JG (2005) Transient memory impairment after acute dose of 75\u00a0mg 3.4-methylenedioxymethamphetamine. J Psychopharmacol 19:633\u2013639","journal-title":"J Psychopharmacol"},{"key":"2532_CR18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00213-006-0321-7","volume":"189","author":"KPC Kuypers","year":"2007","unstructured":"Kuypers KPC, Ramaekers JG (2007) Acute dose of MDMA (75\u00a0mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected. Psychopharmacol 189:557\u2013563","journal-title":"Psychopharmacol"},{"key":"2532_CR19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0269881103174015","volume":"17","author":"CTJ Lamers","year":"2003","unstructured":"Lamers CTJ, Ramaekers JG, Muntjewerff ND, Sikkema KL, Samyn N, Read NL, Brookhuis KA, Riedel WJ (2003) Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance. J Psychopharmacol 17:379\u2013387","journal-title":"J Psychopharmacol"},{"key":"2532_CR20","unstructured":"Lamers CTJ, Rizzo M, Bechara A, Ramaekers J (2006) Simulated driving and attention of repeat users of MDMA and THC compared with THC users and non-drug-using controls. Transportation Research Record, (1969), pp. 50\u201357. ISBN: 0309099781; 978-030909978-3"},{"key":"2532_CR21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/026988110001400313","volume":"14","author":"ME Liechti","year":"2000","unstructured":"Liechti ME, Vollenweider FX (2000) The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('ecstasy') in healthy volunteers. J Psychopharmacol 14:269\u2013274","journal-title":"J Psychopharmacol"},{"key":"2532_CR22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s002130050967","volume":"143","author":"UD McCann","year":"1999","unstructured":"McCann UD, Mertl M, Eligulashvili V, Ricaurte GA (1999) Cognitive performance in (\u00b1) 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') users: a controlled study. Psychopharmacol 143:417\u2013425","journal-title":"Psychopharmacol"},{"key":"2532_CR23","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/sj.npp.1301302","volume":"32","author":"UD McCann","year":"2007","unstructured":"McCann UD, Peterson SC, Ricaurte GA (2007) The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users. Neuropsychopharmacol 32:1695\u20131706","journal-title":"Neuropsychopharmacol"},{"key":"2532_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00207450500535503","volume":"117","author":"M Moon","year":"2007","unstructured":"Moon M, Do KS, Park J, Kim D (2007) Memory impairment in methamphetamine dependent patients. Int J Neurosci 117:1\u20139","journal-title":"Int J Neurosci"},{"key":"2532_CR25","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1037\/0003-066X.54.10.817","volume":"54","author":"AC Parrott","year":"1999","unstructured":"Parrott AC (1999) Does cigarette smoking cause stress? Am Psychol 54:817\u2013820","journal-title":"Am Psychol"},{"key":"2532_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000026666","volume":"42","author":"AC Parrott","year":"2000","unstructured":"Parrott AC (2000) Human research on MDMA (3,4-methylenedioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change. Neuropsychobiology 42:17\u201324","journal-title":"Neuropsychobiology"},{"key":"2532_CR27","doi-asserted-by":"crossref","unstructured":"Parrott AC, Gibbs A, Scholey AB, King R, Owens K, Swann P, Ogden E, Stough C (2011) MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study. Psychopharmacology: 1\u201310","DOI":"10.1007\/s00213-011-2184-9"},{"key":"2532_CR28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/0269881109102780","volume":"24","author":"A Pirona","year":"2010","unstructured":"Pirona A, Morgan MJ (2010) An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users. J Psychopharmacol 24:175\u2013185","journal-title":"J Psychopharmacol"},{"key":"2532_CR29","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/sj.npp.1300894","volume":"31","author":"JG Ramaekers","year":"2006","unstructured":"Ramaekers JG, Kuypers KPC (2006) Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol. Neuropsychopharmacol 31:1048\u20131055","journal-title":"Neuropsychopharmacol"},{"key":"2532_CR30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/0269881108091584","volume":"22","author":"J Ryan","year":"2008","unstructured":"Ryan J, Croft K, Mori T, Wesnes K, Spong J, Downey L, Kure C, Lloyd J, Stough C (2008) An examination of the effects of the antioxidant Pycnogenol\u00ae on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population. J Psychopharmacol 22:553\u2013562","journal-title":"J Psychopharmacol"},{"key":"2532_CR31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jsat.2009.03.004","volume":"37","author":"R Salo","year":"2009","unstructured":"Salo R, Nordahl TE, Galloway GP, Moore CD, Waters C, Leamon MH (2009) Drug abstinence and cognitive control in methamphetamine-dependent individuals. J Subst Abuse Treat 37:292\u2013297","journal-title":"J Subst Abuse Treat"},{"key":"2532_CR32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11065-007-9031-0","volume":"17","author":"JC Scott","year":"2007","unstructured":"Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, Grant I (2007) Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 17:275\u2013297","journal-title":"Neuropsychol Rev"},{"key":"2532_CR33","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1177\/009127009603601109","volume":"36","author":"SA Shappell","year":"1996","unstructured":"Shappell SA, Kearns GL, Valentine JL, Neri DF, DeJohn CA (1996) Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man. J Clin Pharmacol 36:1051\u20131063","journal-title":"J Clin Pharmacol"},{"key":"2532_CR34","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00213-004-2061-x","volume":"179","author":"BY Silber","year":"2005","unstructured":"Silber BY, Papafotiou K, Croft RJ, Ogden E, Swann P, Stough C (2005) The effects of dexamphetamine on simulated driving performance. Psychopharmacol 179:536\u2013543","journal-title":"Psychopharmacol"},{"key":"2532_CR35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00213-006-0410-7","volume":"187","author":"BY Silber","year":"2006","unstructured":"Silber BY, Croft RJ, Papafotiou K, Stough C (2006) The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacol 187:154\u2013169","journal-title":"Psychopharmacol"},{"key":"2532_CR36","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/ptr.2537","volume":"22","author":"C Stough","year":"2008","unstructured":"Stough C, Downey LA, Lloyd J, Silber B, Redman S, Hutchison C, Wesnes K, Nathan PJ (2008) Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90\u00a0day double-blind placebo-controlled randomized trial. Phytother Res 22:1629\u20131634","journal-title":"Phytother Res"},{"key":"2532_CR37","doi-asserted-by":"crossref","unstructured":"Stough C, Downey LA, King R, Papafotiou K, Swann P, Ogden E (2011) The acute effects of 3,4-methylenedioxymethamphetamine and methamphetamine on driving: a simulator study. Accid Anal Prev. doi: 10.1016\/j.aap.2011.08.017","DOI":"10.1016\/j.aap.2011.08.017"},{"key":"2532_CR38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0269881106059486","volume":"20","author":"R Thomasius","year":"2006","unstructured":"Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A (2006) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. J Psychopharmacol (Oxford, England) 20:211\u2013225","journal-title":"J Psychopharmacol (Oxford, England)"},{"key":"2532_CR39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1474-4422(02)00236-3","volume":"1","author":"K Wesnes","year":"2002","unstructured":"Wesnes K, Pincock C (2002) Practice effects on cognitive tasks: a major problem? Lancet Neurol 1:473","journal-title":"Lancet Neurol"},{"key":"2532_CR40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s002130000533","volume":"152","author":"KA Wesnes","year":"2000","unstructured":"Wesnes KA, Ward T, McGinty A, Petrini O (2000) The memory enhancing effects of a Ginkgo biloba\/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacol 152:353\u2013361","journal-title":"Psychopharmacol"},{"key":"2532_CR41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-20586","volume":"23","author":"SR White","year":"2002","unstructured":"White SR (2002) Amphetamine toxicity. Sem Resp Crit Care M 23:27\u201336","journal-title":"Sem Resp Crit Care M"},{"key":"2532_CR42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0376-8716(00)00215-5","volume":"64","author":"AR Winstock","year":"2001","unstructured":"Winstock AR, Griffiths P, Stewart D (2001) Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depen 64:9\u201317","journal-title":"Drug Alcohol Depen"},{"key":"2532_CR43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/hup.873","volume":"22","author":"KK Zakzanis","year":"2007","unstructured":"Zakzanis KK, Campbell Z, Jovanovski D (2007) The neuropsychology of ecstasy (MDMA) use: a quantitative review. Human Psychopharm Clin 22:427\u2013435","journal-title":"Human Psychopharm Clin"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-011-2532-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-011-2532-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-011-2532-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T04:24:21Z","timestamp":1560831861000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-011-2532-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,22]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["2532"],"URL":"https:\/\/doi.org\/10.1007\/s00213-011-2532-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,22]]}}}